Aminoisoquinoline thrombin inhibitor with improved bioavailability
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 30, 2012
Grant Date -
Dec 2, 2010
app pub date -
Aug 6, 2007
filing date -
Aug 8, 2006
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention relates to the compound N-(2-oxo-2-propoxyethyl)-β-phenyl-D-phenyl-alanyl-N-[(1-amino-6-iso-quinolinyl)methyl]-L-prolinamide or a pharmaceutically acceptable salt thereof, to a pharmaceutical composition comprising said compound, as well as to the use of the compound for the manufacture of a medicament for treating or for preventing thrombin mediated diseases.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully